Treatment of Stitch Abscess Following Total Knee Replacement
For a stitch abscess after total knee replacement, initiate empiric treatment with vancomycin 30 mg/kg IV (infused over 120 minutes) as the first-line antibiotic, particularly if the patient has beta-lactam allergies or risk factors for methicillin-resistant organisms. 1
Primary Antibiotic Selection Algorithm
For Patients WITHOUT Beta-Lactam Allergies:
- First choice: Cefazolin 2g IV for empiric coverage of staphylococci (the most common pathogens in prosthetic joint infections) 1
- This provides optimal coverage against methicillin-susceptible Staphylococcus aureus and coagulase-negative staphylococci, which are the predominant organisms in surgical site infections around prosthetic joints 1
- Cefazolin has proven efficacy in orthopedic infections and is the guideline-recommended agent for joint prosthesis-related infections 1
For Patients WITH Cephalosporin or Penicillin Allergies:
- Vancomycin 30 mg/kg IV (infused over 120 minutes) is the recommended alternative 1
- Vancomycin provides comprehensive coverage against both methicillin-susceptible and methicillin-resistant staphylococci 1
- Alternative option: Clindamycin 900 mg IV can be used for beta-lactam allergic patients, though vancomycin is preferred for prosthetic joint infections 1
Critical Risk Factors Requiring Vancomycin as First-Line:
Vancomycin should be selected as the initial empiric antibiotic (even without beta-lactam allergy) in the following situations: 1
- Known or suspected MRSA colonization
- Reoperation in a patient hospitalized in a unit with MRSA ecology
- Previous antibiotic therapy (increases risk of resistant organisms)
- Recent hospitalization or healthcare exposure
Important Clinical Considerations:
Timing and Administration:
- The vancomycin infusion must be completed over 120 minutes to minimize infusion-related reactions 1
- Treatment should be initiated promptly once the diagnosis of stitch abscess is made, as delay increases risk of deeper prosthetic joint infection 1
Duration of Therapy:
- Initial empiric therapy should continue until culture results and sensitivities are available 1
- If debridement is performed with prosthesis retention, transition to pathogen-specific therapy with rifampin-based combination therapy for 3-6 months (6 months for knee, 3 months for hip) after 2-6 weeks of IV antibiotics 1
- Rifampin 300-450 mg orally twice daily combined with a companion drug (ciprofloxacin, levofloxacin, or co-trimoxazole) is recommended for staphylococcal infections when the prosthesis is retained 1
Common Pitfalls to Avoid:
- Do not use cefazolin alone if MRSA risk factors are present – this is a critical error that can lead to treatment failure 1
- Do not delay obtaining cultures before starting antibiotics – aspiration or tissue cultures are essential for definitive pathogen identification 1
- Do not use rifampin as monotherapy – it must always be combined with another antibiotic due to rapid resistance emergence 1
- Monitor renal function closely with vancomycin – nephrotoxicity is a significant concern, especially in elderly patients or those with baseline renal impairment 1
Regarding Beta-Lactam Allergies:
- If the patient reports penicillin or cephalosporin allergy but the reaction was mild (rash only, no anaphylaxis), cefazolin can still be safely administered as cross-reactivity risk is only approximately 2% 2, 3, 4
- Absolute contraindications to cephalosporins include history of Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS syndrome, or organ-specific reactions 2, 3
- For true severe immediate hypersensitivity reactions to beta-lactams, vancomycin remains the safest alternative 1
Surgical Management Considerations:
- A stitch abscess near a prosthetic joint requires urgent surgical evaluation for possible debridement 1
- If the infection is superficial and does not involve the prosthesis, shorter antibiotic courses may be appropriate after surgical drainage 1
- If deep infection is suspected, obtain intraoperative cultures before initiating antibiotics whenever possible to guide definitive therapy 1